Last reviewed · How we verify
NCT04438447: RASTA
ERAS Versus ERAS Plus Artificial Nutrition in Open Pancreatoduodenectomy
NA trial testing parenteral feeding in Pancreas Disease in 240 participants. Status unknown.
10 September 2022
Quick facts
| Lead sponsor | University of Milano Bicocca |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 14 April 2022 |
| Primary completion | 10 September 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- parenteral feeding
Conditions studied
- Pancreas Disease — all drugs for Pancreas Disease →
Sponsor
University of Milano Bicocca
Who can join
Adults 18 to 90, any sex, with Pancreas Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
there is a need of a randomised clinical trial specifically design to explore whether given a full nutritional requirement by parenteral feeding in the first 5 days after surgery coupled with oral food "at will" compared to only oral food "at will", within an established ERAS program, could achieve a reduction of the morbidity burden
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial.
Gianotti L, Paiella S, Capretti G, Pecorelli N, et al · · 2025 · cited 1× · PMID 40896466 · DOI 10.1016/j.eclinm.2025.103455 -
ERAS with or without supplemental artificial nutrition in open pancreatoduodenectomy for cancer. A multicenter, randomized, open labeled trial (RASTA study protocol).
Gianotti L, Paiella S, Frigerio I, Pecorelli N, et al · · 2023 · cited 1× · PMID 37051129 · DOI 10.3389/fnut.2023.1113723 -
Construct Validity and Reliability of the Comprehensive Complication Index as a Morbidity Outcome Measure in Pancreatic Surgery.
Pecorelli N, Fermi F, Abbassi F, Bannone E, et al · · 2025 · PMID 41403005 · DOI 10.1097/sla.0000000000007002
Verify or expand the search:
- PubMed search for NCT04438447
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreas Disease
Currently open trials in the same condition.
- NCT07263061 — Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries · recruiting
- NCT05714111 — Radiology Registry on Pancreatic Malignancies · recruiting
- NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
- NCT03260842 — Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer · recruiting
Other University of Milano Bicocca trials
Trials by the same sponsor.
- NCT07257705 — Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital · NA · completed
- NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
- NCT07407608 — ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 · recruiting
- NCT07479914 — Art of Memory for Cognitive Enhancement in the Monza Brain Health Service · NA · active not recruiting
- NCT07424066 — Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performa · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04438447 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Milano Bicocca
- Last refreshed: 5 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438447.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing